PUBLISHER: The Business Research Company | PRODUCT CODE: 1947106
PUBLISHER: The Business Research Company | PRODUCT CODE: 1947106
Second skin dressing is a transparent, highly flexible, and biocompatible wound covering that closely replicates the natural characteristics of human skin to protect wounds, burns, or surgical sites. It creates a moist environment that supports healing, lowers the risk of infection, improves patient comfort, and reduces scarring to aid faster recovery.
The primary product categories of second skin dressing include hydrocolloid dressings, hydrogel dressings, foam dressings, film dressings, alginate dressings, and others. Hydrocolloid dressings consist of gel-forming materials that absorb wound exudate while preserving a moist healing environment. These products are distributed through hospital pharmacies, retail pharmacies, online pharmacies, and other channels. They are widely applied in the treatment of chronic wounds, acute wounds, surgical wounds, burns, and related conditions, with end users including hospitals, clinics, homecare facilities, and other healthcare settings.
Tariffs have raised costs for imported polymers, adhesives, and medical films used in second skin dressings. North America and europe are most affected due to reliance on specialized raw materials, particularly for hydrocolloid and film dressings. Hospital and retail pharmacy segments face procurement pressure. Positive impacts include increased local production and innovation in cost-effective wound dressing materials.
The second skin dressing market research report is one of a series of new reports from The Business Research Company that provides second skin dressing market statistics, including second skin dressing industry global market size, regional shares, competitors with a second skin dressing market share, detailed second skin dressing market segments, market trends and opportunities, and any further data you may need to thrive in the second skin dressing industry. This second skin dressing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The second skin dressing market size has grown strongly in recent years. It will grow from $2.56 billion in 2025 to $2.77 billion in 2026 at a compound annual growth rate (CAGR) of 8.6%. The growth in the historic period can be attributed to growth in surgical procedures, increasing burn cases, hospital wound care protocols, adoption of moisture healing techniques, expansion of emergency care services.
The second skin dressing market size is expected to see strong growth in the next few years. It will grow to $3.82 billion in 2030 at a compound annual growth rate (CAGR) of 8.3%. The growth in the forecast period can be attributed to rise in chronic wound cases, homecare wound management growth, innovation in biocompatible materials, aging population, expansion of online pharmacies. Major trends in the forecast period include advanced wound protection solutions, transparent and breathable dressings, infection prevention dressings, long-wear flexible dressings, scar minimization technologies.
The increasing number of diabetes cases is expected to contribute to the expansion of the second skin dressing market. Diabetes is a chronic condition marked by elevated blood sugar levels due to the body's inability to produce or properly use insulin. The rise in diabetes is largely attributed to inactive lifestyles and poor dietary habits, which lead to obesity and insulin resistance. Second skin dressings support individuals with diabetes by shielding wounds, preserving a moist healing environment, and minimizing the risk of infection. This is especially important since diabetic patients often experience delayed wound healing. For example, in March 2024, the Office for Health Improvement and Disparities reported that between March 2022 and March 2023, the percentage of patients with type 1 diabetes receiving all eight recommended care processes rose by 22 percent, while those with type 2 diabetes saw a 21 percent increase. Additionally, the percentage of patients reaching target HbA1c levels increased to 37.9 percent, the highest figure ever recorded by the National Diabetes Audit. As a result, the growing prevalence of diabetes is supporting the development of the second skin dressing market.
The rising healthcare expenditure is expected to drive the growth of the second skin dressing market in the coming years. Healthcare expenditure refers to the total financial resources allocated for preventing, diagnosing, treating, and managing health conditions for individuals and populations. This expenditure is increasing due to aging populations requiring more medical services, long-term care, and advanced treatments. Higher healthcare spending supports the Second Skin Dressing market by allowing hospitals, clinics, and patients to afford advanced wound care products, invest in innovative dressings, and implement modern treatment protocols that enhance healing outcomes and reduce complications. For example, in June 2025, according to the US-based federal agency Centers for Medicare & Medicaid Services (CMS), National Health Expenditure (NHE) rose 7.5% to $4.9 trillion in 2023, or $14,570 per person, representing 17.6% of Gross Domestic Product (GDP). Hospital expenditures increased 10.4% to $1,519.7 billion in 2023, outpacing the 3.2% growth recorded in 2022. Thus, the rising healthcare expenditure is contributing to the expansion of the second skin dressing market.
Leading companies in the second skin dressing market are developing innovative products such as advanced plasters to accelerate healing, enhance patient comfort, and lower the risk of infection and scarring. These advanced plasters are designed to replicate the properties of natural skin, offering features such as flexibility, transparency, breathability, and controlled drug release to support faster and more effective wound healing. In January 2025, Beiersdorf AG, a manufacturing company based in Germany, introduced a Second Skin Protection plaster designed to improve wound coverage and healing speed. It utilizes hydrocolloid technology to absorb fluid and maintain a moist environment, which encourages faster healing and reduces the chances of infection and visible scarring. The plaster is ultra-thin, waterproof, and flexible, providing a secure fit even on difficult areas such as elbows and knees. It aims to deliver a high-quality treatment for everyday minor injuries while educating users about the benefits of modern wound care practices and moving away from outdated approaches.
Major companies operating in the second skin dressing market are Cardinal Health Inc., Avery Dennison Corporation, Nitto Denko Corporation, Smith & Nephew plc, Coloplast A/S, Hartmann Group, ConvaTec Group PLC, Integra LifeSciences, DeRoyal Industries Inc., Winner Medical Co. Ltd., Scapa Healthcare, DermaRite Industries LLC, Anhui Jinye Industrial Co. Ltd., ACTO GmbH, Beiersdorf AG, Advancis Medical, Amparo Medical Technologies Inc., Gujarat Healthcare, Jiangsu WLD Medical Co. Ltd., Wuhan Huawei Technology Co. Ltd., Yangzhou Goldenwell Import & Export Co. Ltd., Zhejiang Bangli Medical Products Co. Ltd.
North America was the largest region in the second skin dressing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the second skin dressing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the second skin dressing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain
The second skin dressing market consists of sales of silicone dressings, polyurethane dressings, and collagen dressings. Values in this market are 'factory gate' values; that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Second Skin Dressing Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses second skin dressing market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for second skin dressing ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The second skin dressing market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.